Originally published by our sister publication Pain Medicine News
Data from a recent study indicate that two weeks of ad libitum edible cannabis use has a broad range of benefits for people being treated for solid tumor cancers, including improvements in their experience of pain.
Twenty-five participants (mean age, 54.3 years; 13 females) were included in the study (Explor Med 2023;4:254-271).
Participants used an edible cannabis product for an average 8.1 days and ingested a total of 116.4 mg of